Cigna Group (NYSE:CI) Shares Unloaded Rep. Gilbert Ray Cisneros, Jr.

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of Cigna Group (NYSE:CI). In a filing disclosed on April 07th, the Representative disclosed that they had sold between $1,001 and $15,000 in Cigna Group stock on March 13th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

  • Sold $1,001 – $15,000 in shares of MACOM Technology Solutions (NASDAQ:MTSI) on 3/27/2026.
  • Purchased $1,001 – $15,000 in shares of StandardAero (NYSE:SARO) on 3/27/2026.
  • Purchased $1,001 – $15,000 in shares of FirstService (NASDAQ:FSV) on 3/27/2026.
  • Sold $1,001 – $15,000 in shares of Charles Schwab (NYSE:SCHW) on 3/27/2026.
  • Sold $1,001 – $15,000 in shares of Advanced Energy Industries (NASDAQ:AEIS) on 3/27/2026.
  • Sold $1,001 – $15,000 in shares of Flex (NASDAQ:FLEX) on 3/27/2026.
  • Purchased $1,001 – $15,000 in shares of LPL Financial (NASDAQ:LPLA) on 3/27/2026.
  • Purchased $1,001 – $15,000 in shares of DoorDash (NASDAQ:DASH) on 3/27/2026.
  • Sold $1,001 – $15,000 in shares of Viavi Solutions (NASDAQ:VIAV) on 3/27/2026.
  • Purchased $15,001 – $50,000 in shares of Fabrinet (NYSE:FN) on 3/27/2026.

Cigna Group Stock Down 0.1%

CI stock traded down $0.39 during midday trading on Thursday, reaching $277.17. 169,013 shares of the company’s stock traded hands, compared to its average volume of 1,711,468. The company has a market cap of $73.04 billion, a price-to-earnings ratio of 12.51, a P/E/G ratio of 0.94 and a beta of 0.26. The firm’s fifty day moving average price is $276.26 and its 200-day moving average price is $278.75. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. The firm had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, sell-side analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th were paid a dividend of $1.56 per share. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date was Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is presently 28.13%.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a report on Tuesday, February 10th. Mizuho set a $325.00 price target on shares of Cigna Group in a report on Friday, January 9th. Zacks Research raised shares of Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. Piper Sandler dropped their price objective on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, March 3rd. Finally, Truist Financial increased their price target on shares of Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a report on Tuesday, February 17th. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, Cigna Group currently has an average rating of “Moderate Buy” and an average target price of $333.11.

Get Our Latest Report on CI

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Wilkerson Advisory Group LLC bought a new position in shares of Cigna Group in the fourth quarter worth approximately $25,000. Harbor Capital Advisors Inc. boosted its holdings in Cigna Group by 119.5% in the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after acquiring an additional 49 shares in the last quarter. Beacon Financial Strategies CORP bought a new stake in Cigna Group in the fourth quarter valued at $28,000. Kemnay Advisory Services Inc. bought a new stake in Cigna Group in the fourth quarter valued at $29,000. Finally, Prosperity Bancshares Inc bought a new stake in Cigna Group in the fourth quarter valued at $29,000. Institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling at Cigna Group

In related news, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the sale, the insider owned 5,670 shares in the company, valued at $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 0.60% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Cigna Group Company Profile

(Get Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Articles

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.